Hammerco Lawyers has filed a class action lawsuit on behalf of Canadian residents in light of Health Canada’s drug recall advisory on March 9.
Multiple lots of Losartan-containing drugs are being voluntarily recalled by Teva Canada, Apotex Inc., Pharmascience Inc., and Pro Doc Limitée because of the potential for a nitrosamine impurity, N-Nitroso-N-methyl-4-aminobutyric acid (NMBA).
NMBA is potentially a human carcinogen, which means that long-term exposure could increase the potential risk of cancer.
Please contact Kevin McLaren if you think you may have been affected by the Losartan drug recall.
More News & Resources
June 19, 2024
Estate matters can be emotionally charged and made more complex when it comes to the question of whether cultural norms and traditions can justify disinheriting one child over another.
May 5, 2024
Special considerations apply to Indigenous estates and wills made by Indigenous persons.
May 1, 2024
This decision protects the ability of individuals who have suffered violence within a marriage to resolve the separation or divorce proceedings without barring them to bring a future claim relating to assault that occ...
April 18, 2024
Hammerco is proud to announce that Partner Krista Simon has been appointed a member of the Judicial Council of the Tsawwassen First Nation for a five-year term.